Junk food-induced obesity-a growing threat to youngsters during the pandemic A Singh, D Dhanasekaran, N Ganamurali, L Preethi, S Sabarathinam Obesity Medicine 26, 100364, 2021 | 49 | 2021 |
Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect L Preethi, N Ganamurali, D Dhanasekaran, S Sabarathinam Obesity Medicine 24, 100346, 2021 | 35 | 2021 |
Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases SR SK, PA Anuba, B Swetha, PM Aishwarya, S Sabarathinam Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (3), 102451, 2022 | 29 | 2022 |
Green synthesis of silver nanoparticles from Cassia Auriculata: Targeting antibacterial, antioxidant activity, and evaluation of their possible effects on saltwater … C Kamaraj, C Ragavendran, K Manimaran, S Sarvesh, ARMT Islam, ... Science of the Total Environment 861, 160575, 2023 | 23 | 2023 |
Prevalence and pattern of usage of complementary and alternative medicine among south Indian asthma patients in a tertiary care hospital S Sarvesh, MKM Raja, MG Rajanandh, P Seenivasan Complementary Therapies in Clinical Practice 30, 103-108, 2018 | 17 | 2018 |
Synthesize palladium nanoparticles from the macroalgae Sargassum fusiforme: An eco-friendly tool in the fight against Plasmodium falciparum? C Kamaraj, C Ragavendran, RCS Kumar, S Sabarathinam, C Vetrivel, ... Science of The Total Environment 857, 159517, 2023 | 16 | 2023 |
Synthesis and in vitro studies for structure-based design of novel chalcones as antitubercular agents targeting InhA SS L S DHIVYA, BR PRADEEPA FUTURE MEDICINAL CHEMISTRY, 2022 | 14 | 2022 |
Isomers of guggulsterone in hyperlipidemia S Sabarathinam, TM Vijayakumar Obesity medicine 22, 100326, 2021 | 12 | 2021 |
CYP3A4 mediated pharmacokinetics drug interaction potential of Maha-Yogaraj Gugglu and E, Z guggulsterone VTM Sarvesh Sabarathinam, Satish Kumar Rajappan Chandra scientific report, 2021 | 11 | 2021 |
Network pharmacology based pharmacokinetic assessment and evaluation of the therapeutic potential of catechin derivatives as a potential myostatin inhibitor: A special view on … SKRCSS Sarvesh Sabarathinam Natural Product Research, 2023 | 10* | 2023 |
Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence LS Dhivya, S Sarvesh Journal of Biomolecular Structure and Dynamics 41 (12), 5399-5417, 2023 | 9 | 2023 |
Isolation and In silico Study of Curcumin from Curcuma longa and Its Anti-Diabetic Activity DLSSS Mariyappan Vaithiyalingam Applied Biochemistry and Biotechnology 194 (10), 2022 | 9* | 2022 |
A glycemic diet improves the understanding of glycemic control in diabetes patients during their follow-up S Sabarathinam Future Science OA, 2023 | 8 | 2023 |
The role of guggulsterone on the NF-κB pathway in inflammatory bowel disease: preclinical evidence SKS Priya, A Jha, RC Satish Kumar, S Sabarathinam Future Science OA 8 (6), FSO803, 2022 | 8 | 2022 |
Chalcones reloaded: an integration of network pharmacology and molecular docking for type 2 diabetes therapy NG Sarvesh Sabarathinam Journal of Biomolecular structure and dynamics, 2023 | 7 | 2023 |
Bempedoic acid: a nonstatin drug for the management of hypercholesterolemia A Govindaraju, S Sabarathinam Health Science Reports 4 (4), 2021 | 7 | 2021 |
Assessment of herb-drug interactions based on the pharmacokinetic changes of probe drug, midazolam S Sabarathinam, TM Vijayakumar Drug Metabolism Letters 14 (1), 5-8, 2021 | 7 | 2021 |
A narrative review on the impact of processed foods/junk foods/preserved foods: Why special attention is required to prevent metabolic syndrome? SS Divya Saravanan, Suhana Khatoon B Obesity Medicine 42, 2023 | 6* | 2023 |
A short exploration of selected sensitive CYP3A4 substrates (Probe Drug) TMV sarvesh sabarathinam Drug Metabolism Letters 14 (01), DOI: 10.2174/1872312814666200811110024, 2020 | 6* | 2020 |
RP-hplc method development and validation of midazolam: A cyp3a4 probe drug S Sabarathinam, TM Vijayakumar Research Journal of Pharmacy and Technology 13 (8), 3565-3568, 2020 | 6 | 2020 |